Mechanism of polycomb recruitment to CpG islands revealed by inherited disease-associated mutation

Human Molecular Genetics

Volumn 22, Issue 16, 2013, Pages 3187-3194

  Caputo, Valentina S ^a   Costa, Joana R ^a,b   Makarona, Kalliopi ^a   Georgiou, Elisabeth ^a,c   Layton, D Mark ^a   Roberts, Irene ^a   Karadimitris, Anastasios ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NOVA MEDICAL SCHOOL   (Portugal)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEAZANEPLANOCIN A; ACTIVATING TRANSCRIPTION FACTOR; BUTYRIC ACID; MITOMYCIN A; POLYCOMB GROUP PROTEIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHROMATIN; CONTROLLED STUDY; CPG ISLAND; DNA BINDING; GENE MUTATION; GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY; HISTONE ACETYLATION; HOUSEKEEPING GENE; HOUSEKEEPING GENE PIGM; HUMAN; HUMAN CELL; INTRACTABLE EPILEPSY; NUCLEOSOME; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

ACTIVATING TRANSCRIPTION FACTORS; B-LYMPHOCYTES; BASE SEQUENCE; CELLS, CULTURED; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, ESSENTIAL; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMOGLOBINURIA, PAROXYSMAL; HISTONES; HUMANS; MANNOSYLTRANSFERASES; MOLECULAR SEQUENCE DATA; NUCLEOSOMES; POINT MUTATION; POLYCOMB-GROUP PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING;

EID: 84881228431     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt171     Document Type: Article

References (36)

1. Simon, J.A. and Kingston, R.E. (2009) Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell. Biol., 10, 697-708.
2. Almeida, A.M., Murakami, Y., Layton, D.M., Hillmen, P., Sellick, G.S., Maeda, Y., Richards, S., Patterson, S., Kotsianidis, I., Mollica, L. et al. (2006) Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency. Nat. Med., 12, 846-851.
3. Almeida, A., Layton, M. and Karadimitris, A. (2009) Inherited glycosylphosphatidyl inositol deficiency: a treatable CDG. Biochim. Biophys. Acta., 1792, 874-880.
4. Almeida, A.M., Murakami, Y., Baker, A., Maeda, Y., Roberts, I.A., Kinoshita, T., Layton, D.M. and Karadimitris, A. (2007) Targeted therapy for inherited GPI deficiency. N. Engl. J. Med., 356, 1641-1647.
5. Davie, J.R. (2003) Inhibition of histone deacetylase activity by butyrate. J. Nutr., 133, 2485S-2493S.
6. Malek, A., Nunez, L.E., Magistri, M., Brambilla, L., Jovic, S., Carbone, G.M., Moris, F. and Catapano, C.V. (2012) Modulation of the activity of sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer. PLoS ONE, 7, e35130.
7. Blume, S.W., Snyder, R.C., Ray, R., Thomas, S., Koller, C.A. and Miller, D.M. (1991) Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin. Invest., 88, 1613-1621.
8. Barceló , F., Scotta, C., Ortiz-Lombardía, M., Méndez, C., Salas, J.A. and Portugal, J. (2007) Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences. Nucleic Acids Res., 35, 2215-2226.
9. Blackledge, N.P. and Klose, R. (2011) CpG island chromatin: a platform for gene regulation. Epigenetics, 6, 147-152.
10. Deaton, A.M. and Bird, A. (2011) CpG islands and the regulation of transcription. Genes Dev., 25, 1010-1022.
11. Ramirez-Carrozzi, V.R., Braas, D., Bhatt, D.M., Cheng, C.S., Hong, C., Doty, K.R., Black, J.C., Hoffmann, A., Carey, M. and Smale, S.T. (2009) A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell, 138, 114-128.
12. Hargreaves, D.C., Horng, T. and Medzhitov, R. (2009) Control of inducible gene expression by signal-dependent transcriptional elongation. Cell, 138, 129-145.
13. Beisel, C. and Paro, R. (2011) Silencing chromatin: comparing modes and mechanisms. Nat. Rev. Genet., 12, 123-135.
14. Kouzarides, T. (2007) Chromatin modifications and their function. Cell, 128, 693-705.
15. Bracken, A.P. and Helin, K. (2009) Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer, 9, 773-784.
16. Guenther, M.G. and Young, R.A. (2010) Transcription. Repressive transcription. Science, 329, 150-151.
17. Landeira, D., Sauer, S., Poot, R., Dvorkina, M., Mazzarella, L., Jorgensen, H.F., Pereira, C.F., Leleu, M., Piccolo, F.M., Spivakov, M. et al. (2010) Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1andRNAPolymerase II to developmental regulators. Nat. Cell. Biol., 12, 618-624.
18. Shen, X., Kim, W., Fujiwara, Y., Simon, M.D., Liu, Y., Mysliwiec, M.R., Yuan, G.C., Lee, Y. and Orkin, S.H. (2009) Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell, 139, 1303-1314.
19. Miranda, T.B., Cortez, C.C., Yoo, C.B., Liang, G., Abe, M., Kelly, T.K., Marquez, V.E. and Jones, P.A. (2009) DZNepis a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer Ther., 8, 1579-1588.
20. Xie, Z., Bi, C., Cheong, L.L., Liu, S.C., Huang, G., Zhou, J., Yu, Q., Chen, C.S. and Chng, W.J. (2011) Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cells. PLoS ONE, 6, e21583.
21. Zhang, X., Zhao, X., Fiskus, W., Lin, J., Lwin, T., Rao, R., Zhang, Y., Chan, J.C., Fu, K., Marquez, V.E. et al. (2012) Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-cell lymphomas. Cancer Cell, 22, 506-523.
22. Bernstein, B.E., Meissner, A. and Lander, E.S. (2007) The mammalian epigenome. Cell, 128, 669-681.
23. Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K. et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell, 125, 315-326.
24. Azuara, V., Perry, P., Sauer, S., Spivakov, M., Jorgensen, H.F., John, R.M., Gouti, M., Casanova, M., Warnes, G., Merkenschlager, M. et al. (2006) Chromatin signatures of pluripotent cell lines. Nat. Cell Biol., 8, 532-538.
25. Fisher, C.L. and Fisher, A.G. (2011) Chromatin states in pluripotent, differentiated, and reprogrammed cells. Curr. Opin. Genet. Dev., 21, 140-146.
26. Thomson, J.P., Skene, P.J., Selfridge, J., Clouaire, T., Guy, J., Webb, S., Kerr, A.R., Deaton, A., Andrews, R., James, K.D. et al. (2010) CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature, 464, 1082-1086.
27. Ku, M., Koche, R.P., Rheinbay, E., Mendenhall, E.M., Endoh, M., Mikkelsen, T.S., Presser, A., Nusbaum, C., Xie, X., Chi, A.S. et al. (2008) Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet., 4, e1000242.
28. Lynch, M.D., Smith, A.J., De, G.M., Flenley, M., Hughes, J.R., Vernimmen, D., Ayyub, H., Sharpe, J.A., Sloane-Stanley, J.A., Sutherland, L. et al. (2012) An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment. EMBO J., 31, 317-329.
29. Mendenhall, E.M., Koche, R.P., Truong, T., Zhou, V.W., Issac, B., Chi, A.S., Ku, M. and Bernstein, B.E. (2010) GC-rich sequence elements recruit PRC2 in mammalian ES cells. PLoS Genet., 6, e1001244.
30. Jones, P.A. (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet., 13, 484-492.
31. Thurman, R.E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M.T., Haugen, E., Sheffield, N.C., Stergachis, A.B., Wang, H., Vernot, B. et al. (2012) The accessible chromatin landscape of the human genome. Nature, 489, 75-82.
32. Brandeis, M., Frank, D., Keshet, I., Siegfried, Z., Mendelsohn, M., Nemes, A., Temper, V., Razin, A. and Cedar, H. (1994) Sp1 elements protect a CpG island from de novo methylation. Nature, 371, 435-438.
33. Macleod, D., Charlton, J., Mullins, J. and Bird, A.P. (1994) Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev., 8, 2282-2292.
34. Weber, M., Hellmann, I., Stadler, M.B., Ramos, L., Paabo, S., Rebhan, M. and Schubeler, D. (2007) Distribution, silencing potential and evolutionary impact of promoterDNAmethylation in the human genome. Nat. Genet., 39, 457-466.
35. Ooi, S.K., Qiu, C., Bernstein, E., Li, K., Jia, D., Yang, Z., Erdjument-Bromage, H., Tempst, P., Lin, S.P., Allis, C.D. et al. (2007) DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature, 448, 714-717.
36. Marin, M., Karis, A., Visser, P., Grosveld, F. and Philipsen, S. (1997) Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell, 89, 619-628.